Table 1. Correlation between NKX2.1 expression and clinicopathological variables of 205 gastric cancer cases.
Clinicopathological parameters | n a | NKX2.1 Expression | χ2 | P Value | |
Low | High | ||||
All | 205 | 87 | 118 | ||
Age (years) | |||||
<55 | 84 | 25 | 59 | 9.363 | 0.002* |
≥55 | 121 | 62 | 59 | ||
Gender | 0.031 | 0.861 | |||
Male | 74 | 32 | 42 | ||
Female | 131 | 55 | 76 | ||
Tumor size | 8.088 | 0.004* | |||
<3 cm | 40 | 9 | 31 | ||
≥3 cm | 165 | 78 | 87 | ||
Tumor infiltration | 24.503 | <0.001* | |||
T1 | 32 | 5 | 27 | ||
T2 | 22 | 3 | 19 | ||
T3 | 16 | 9 | 7 | ||
T4a | 104 | 51 | 53 | ||
T4b | 31 | 19 | 12 | ||
Local lymph node metastasis | 3.468 | 0.325 | |||
N0 | 66 | 24 | 42 | ||
N1 | 38 | 19 | 19 | ||
N2 | 39 | 14 | 25 | ||
N3 | 62 | 30 | 32 | ||
Distant metastasis | 0.257 | 0.612 | |||
M0 | 184 | 77 | 107 | ||
M1 | 21 | 10 | 11 | ||
TNM staging | 21.330 | <0.001* | |||
I | 42 | 5 | 37 | ||
II | 38 | 22 | 16 | ||
III | 104 | 50 | 54 | ||
IV | 21 | 10 | 11 |
Numbers of cases in each group.
*Statistically significant (P<0.05).